Back to Search Start Over

Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits.

Authors :
Frommeyer, Gerrit
Kaiser, Dennis
Uphaus, Timo
Kaese, Sven
Osada, Nani
Rajamani, Sridharan
Belardinelli, Luiz
Breithardt, Günter
Eckardt, Lars
Milberg, Peter
Source :
Heart Rhythm; Dec2012, Vol. 9 Issue 12, p2051-2058, 8p
Publication Year :
2012

Abstract

BACKGROUND: Ranolazine exhibits a synergistic effect in combination with class III drugs to suppress atrial fibrillation. OBJECTIVE: To investigate whether a combination therapy affects repolarization and provokes ventricular tachyarrhythmias (VT) in a sensitive model of proarrhythmia. METHODS: Thirty-seven rabbits were assigned to 3 groups and fed with amiodarone (50 mg/kg/d; n = 10) or dronedarone (50 mg/kg/d; n = 10) over a period of 6 weeks. A third group was used as control (n = 17). After obtaining baseline data in Langendorff-perfused control hearts, sotalol (100 μM) was administered in this group. Thereafter, ranolazine (10 μM) was additionally infused on top of amiodarone, dronedarone, or sotalol. RESULTS: Chronic treatment with amiodarone or dronedarone as well as sotalol significantly increased action potential duration at 90% repolarization (APD<subscript>90</subscript>). Additional treatment with ranolazine further increased APD<subscript>90</subscript> in amiodarone- and dronedarone-pretreated hearts but not in sotalol-treated hearts. Ranolazine increased postrepolarization refractoriness as compared with amiodarone or dronedarone alone owing to a marked effect on the refractory period. In contrast to amiodarone and dronedarone, acute application of sotalol increased dispersion of repolarization (P < .05). Additional treatment with ranolazine did not further increase spatial or temporal dispersion. After lowering extracellular [K<superscript>+</superscript>] in bradycardic hearts, no proarrhythmia occurred in amiodarone- or dronedarone-treated hearts whereas 11 of 17 sotalol-treated hearts showed early afterdepolarizations and subsequent polymorphic VT. Additional treatment with ranolazine reduced the number of VT episodes in sotalol-treated hearts and did not cause proarrhythmia in combination with amiodarone or dronedarone. CONCLUSIONS: Application of ranolazine on top of class III drugs does not cause proarrhythmia despite a marked effect on ventricular repolarization. The effect of ranolazine on the repolarization reserve is associated with the lack of effect on early afterdepolarizations and dispersion of repolarization. [Copyright &y& Elsevier]

Details

Language :
English
ISSN :
15475271
Volume :
9
Issue :
12
Database :
Supplemental Index
Journal :
Heart Rhythm
Publication Type :
Academic Journal
Accession number :
83871641
Full Text :
https://doi.org/10.1016/j.hrthm.2012.08.029